August 02, 2025 a 07:43 am
DGX: Fundamental Ratio Analysis - Quest Diagnostics Incorporated
Quest Diagnostics Incorporated is a leading provider in the healthcare sector, especially in diagnostic testing and information services. With a long history and solid presence, the company shows steady performance in the medical diagnostics industry. Investors may find potential in its consistent service delivery despite market fluctuations.
Fundamental Rating (H2)
The fundamental data suggests a diverse score range, indicating strengths in certain areas and weaknesses in others.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
Historical Rating
The historical data provides insight into the company's performance stability over time.
| Date | Overall Score | DCF | ROE | ROA | Debt to Equity | Price to Earnings | Price to Book |
|---|---|---|---|---|---|---|---|
| 2025-08-01 | 3 | 5 | 4 | 4 | 1 | 2 | 3 |
Analyst Price Targets
Current analyst price targets signal a slightly bullish outlook with a balanced spread.
| High | Low | Median | Consensus |
|---|---|---|---|
| 195 | 180 | 185 | 186.67 |
Analyst Sentiment
The analyst sentiment consists largely of 'Hold' recommendations, reflecting a balanced outlook.
| Recommendation | Number | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 14 | |
| Hold | 17 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Quest Diagnostics exhibits a stable performance record with moderate growth potential in its fundamental metrics. The company's diagnostic delivery services offer a reliable business foundation. While there are some low scores in areas like Debt to Equity, the strong analyst ratings and price targets suggest potential upside. Investors should weigh the stable but not overly aggressive growth prospects in assessing their investment strategy.